TABLE 1.
Enrolled Patient Characteristics
| Enrolled patients (N = 22) | |
|---|---|
| Age (years) | |
| Mean (SD) | 56.0 (8.8) |
| Range | 39–69 |
| Reconstruction, n (%) | |
| None | 12 (54.5) |
| Saline implant | 1 (4.5) |
| Silicone implant | 8 (36.4) |
| Flap | 1 (4.5) |
| Radiation dose to chest wall, n (%) | |
| 4,800 cGY, 24 fractions | 1 (4.5) |
| 5,000 cGY, 25 fractions | 11 (50.0) |
| 5,040 cGY, 28 fractions | 7 (31.8) |
| Information not available | 3 (13.6) |
| Acute radiation dermatitis grade, n (%)a | |
| Grade 1 | 4 (18.2) |
| Grade 2 | 10 (45.5) |
| Grade 3 | 5 (22.7) |
| Grade 4 | 2 (9.1) |
| No acute radiation dermatitis reported | 1 (4.5) |
| Time between RT and RIBT appearance n (%) | |
| < 6 months | 8 (36.4) |
| 6–12 months | 8 (36.4) |
| >1–2 years | 2 (9.1) |
| > 2 years | 3 (13.6) |
| Not reported | 1 (4.5) |
| Years since RT | |
| Mean (SD) | 7.7 (4.1) |
| Range | 2–17 |
| Clinical RIBT severity score | |
| Mean (SD) | 7.0 (1.6) |
| Range | 3–10 |
| Telangiectasia location, n (%) | |
| Chest wall/breast | 2 (9.1) |
| Chest wall/breast and axilla | 3 (13.6) |
| Chest wall/breast and décolletage | 4 (18.2) |
| Chest wall/breast, axilla, and décolletage | 13 (59.1) |
SD, standard deviation; RT, radiation therapy; RIBT, radiation-induced breast telangiectasias.
a
Grade 1, faint erythema or dry desquamation; Grade 2, moderate to brisk erythema, patchy moist desquamation, mostly confined to skin folds and creases, moderate edema; Grade 3, moist desquamation other than skin folds and creases, bleeding induced by minor trauma or abrasion; Grade 4, skin necrosis or ulceration of full thickness dermis, spontaneous bleeding from involved site.